115 related articles for article (PubMed ID: 7521755)
1. Vasoactive intestinal peptide (VIP) inhibits substrate adherence capacity of rat peritoneal macrophages by a mechanism that involves cAMP.
Segura JJ; Guerrero JM; López-Gonzalez MA; Calvo JR
Cell Adhes Commun; 1993 Dec; 1(3):213-21. PubMed ID: 7521755
[TBL] [Abstract][Full Text] [Related]
2. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages.
Segura JJ; Guerrero JM; Goberna R; Calvo JR
Regul Pept; 1992 Feb; 37(3):195-203. PubMed ID: 1372999
[TBL] [Abstract][Full Text] [Related]
3. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.
Pozo D; Montilla ML; Guerrero JM; Calvo JR
Eur J Pharmacol; 1997 Mar; 321(3):379-86. PubMed ID: 9085051
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility.
Garrido E; Delgado M; Martínez C; Gomariz RP; De la Fuente M
Neuropeptides; 1996 Dec; 30(6):583-95. PubMed ID: 9004257
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages.
de la Fuente M; Delgado M; del Rio M; Garrido E; Leceta J; Hernanz A; Gomariz RP
Peptides; 1994; 15(7):1157-63. PubMed ID: 7854966
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
Van Valen F; Jürgens H; Winkelmann W; Keck E
Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of vasoactive intestinal peptide (VIP) on phagocytosis in mouse peritoneal macrophages.
Ichinose M; Sawada M; Maeno T
Regul Pept; 1994 Dec; 54(2-3):457-66. PubMed ID: 7536335
[TBL] [Abstract][Full Text] [Related]
10. Effect of pituitary adenylate cyclase activating polypeptide on vasopressin-induced proliferation of aortic smooth muscle cells: comparison with vasoactive intestinal polypeptide.
Oiso Y; Kotoyori J; Murase T; Ito Y; Kozawa O
Biochem Cell Biol; 1993; 71(3-4):156-61. PubMed ID: 7691092
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin inhibition of VIP- and isoproterenol-stimulated cyclic AMP production in rat peritoneal macrophages.
Segura JJ; Guerrero JM; Goberna R; Calvo JR
Neuropeptides; 1992 Sep; 23(1):39-43. PubMed ID: 1357581
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat.
Carter RF; Bitar KN; Zfass AM; Makhlouf GM
Gastroenterology; 1978 Apr; 74(4):726-30. PubMed ID: 204536
[TBL] [Abstract][Full Text] [Related]
13. Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages.
Pozo D; Guerrero JM; Calvo JR
Peptides; 1995; 16(2):313-8. PubMed ID: 7784261
[TBL] [Abstract][Full Text] [Related]
14. VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF).
Cox CP; Linden J; Said SI
Peptides; 1984; 5(2):325-8. PubMed ID: 6206481
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide (VIP) inhibits TGF-beta1 production in murine macrophages.
Sun W; Tadmori I; Yang L; Delgado M; Ganea D
J Neuroimmunol; 2000 Jul; 107(1):88-99. PubMed ID: 10808055
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
17. Mode of action of somatostatin to inhibit secretion by shark rectal gland.
Silva P; Stoff JS; Leone DR; Epstein FH
Am J Physiol; 1985 Sep; 249(3 Pt 2):R329-34. PubMed ID: 2863985
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism.
Wiik P
Regul Pept; 1989 May; 25(2):187-97. PubMed ID: 2474178
[TBL] [Abstract][Full Text] [Related]
19. Secretin and vasoactive intestinal peptide are potent stimulants of cellular contraction and accumulation of cyclic AMP in rat ventricular cardiomyocytes.
Bell D; McDermott BJ
J Cardiovasc Pharmacol; 1994 Jun; 23(6):959-69. PubMed ID: 7523789
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and forskolin stimulate interleukin 6 production by rat cortical astrocytes in culture via a cyclic AMP-dependent, prostaglandin-independent mechanism.
Grimaldi M; Pozzoli G; Navarra P; Preziosi P; Schettini G
J Neurochem; 1994 Jul; 63(1):344-50. PubMed ID: 8207438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
